최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국응용생명화학회지 = Journal of the Korean Society for Applied Biological Chemistry, v.50 no.3, 2007년, pp.147 - 153
성민규 (충남대학교 농업생명과학대학, 응용생물화학부) , 주성모 (충남대학교 농업생명과학대학, 응용생물화학부) , 송아름 (충남대학교 농업생명과학대학, 응용생물화학부) , 성낙도 (충남대학교 농업생명과학대학, 응용생물화학부)
To search for a molecular design of a new breast cancerous inhibitory active compound, 2D-QSAR and HQSAR between the substituents of flavopiridol analogues as substrates and their breast cancerous inhibitory activities against MCF-7 cell were analyzed and discussed quantitatively. It was found that ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Hunter, T. and Pines, J. (1994) Cyclins and cancer. II Cyclin D and CDK inhibitors come of age. Cell. 79, 573-582
Morgan, D. O. (1995) Principles of CDK regulations. Nat. 374, 131-134
Sherr. C. J. (1994) G1 phase progression: cyclin on cue. Cell. 79, 551-555
Reed, S. I., Bailly, E., Dulic, V., Hengst, L., Resnitzky, D. and Slingerland, J. (1994) G1 control in mammalian cells. J. Cell. Sci. 18(suppl.), 69-73
Norbury, C. and Nurse, P. (1992) Animal cell cycles and their control. Ann. Rev. Biochem. 61, 441-470
Solomon, M. J. (1993) Activation of the various cyclin/CDC 2 proteins. Curr. Opin. Cell Biol. 5, 180-186
Jiang, M., Shao, Z. M., Wu, J., Lu, J. S., Yu, L. M., Yuan, J. D., Han, Q. X., Shen, Z. Z. and Fontana, J. A. (1997) p21waf1/cipl and mdm-2 expression to prognosis. Int. J. Cancer. 74, 529- 534
Barbareschi, M., Caffo, O., Doglioni, C., Fina, P., Marchetti, A., Buttitta, F., Leek, R., Morelli, L., Leonardi, E., Bevilacqua, G., Dalla, P. P. and Harris, A. L. (1996) p21 WAF1 immunohistochemical expression in breast carcinoma: correlation with clinocopathologic data, aestrogen receptor status, MIBI expression, p53 genes and protein alterations and relapse-free survival. Br. J. Cancer 74, 208-215
Johnson, E. A., Davidson, A. G. and Hostetter, P. B. (1996) The expression of WAF1in node-negative infiltrating ductal breast carcinoma. Proc. Am. Assoc. Cancer Res. 37, 569
Ahn, Y. M., Vogeti, L., Liu, C. J., Santhapuram, H. K. R., White, J. M. Vasandani, V. Mitscher, L. A., Lushington, G. H., Hanson, P. R., Powell, D. R., Himes, R. H., Roby, K. F., Ye, Q. and Georg, G. I. (2007) Design, synthesis, and antiproliferative and CDK2 -cyclin A inhibitory activity of novel flavopiridol analogues. Bioorg. Medi. Chem. 15, 702-713
Guo, J., Zhou, A. W., Fu, Y. C., Verma, U. N., Tripathy, D., Frenkel, E. P. and Becerra, C. R. (2006) Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-flurouracil. Act. Phar. Sin. 27, 1375-1381
Harris M., Piskorska-Pliszczynska J., Zacharewski T., Romkes M. and Safe S. (1989) Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and charaterization of the Ah receptor. Cancer Res. 49, 4531-4535
Ivy, S. P., Tulpule, A., Fairchild, C. R., Averbuch, S. D., Myers, C. E., Nebert, D. W., Baird, W. M. and Cowan, K. H. (1988) Altered regulation of P-450IA1 expression in a multidrug resistant MCF-7 human breast cancer cell lines. J. Biol. Chem. 263, 19119-19125
Chen, W. F., Huang, M. H., Tzang, C. H., Yang, M. and Wong, M. S. (2003) Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1638, 187-196
Kubinyi, H. (1993) In Hansch Analysis and Relates Approaches. VCH. Weinheim, Chap. 4
Sung, N. D. (2002) Development of new agrochemicals by quantitative structure-activity relationship (QSAR) methodology. II. The linear free energy relationship (LFER) and descriptors. Korean J. Pestic. Sci. 6, 231-243
Heritage, H. H. and Zacher, H. (1999) Molecular Hologram QSAR, In Rational Drug Design; Novel Methodology and Prractical Applications. (Parrill, A. L. and Reddy, M. R. Ed.), ACS Symposium Series 719, American Chemical Society, Washington, D.C., Ch. 4
Chen, W. F., Huang, M. H., Tzang, C. H., Yang, M. and Wong, M. S. (2003) Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1638, 187-196
TSAR (Ver. 3.3) (2000) Proprietary Software, Oxford Molecular Ltd
Tripos, Sybyl (2006) Molecular Modeling and QSAR software on CD-Rom (Ver. 7.3), Triopos Associates, Inc., Suite 303, St. Louis, MO
Tipker, J. and Verloop, A. (1984) In The chemistry of Excitation at Interfaces. Washington, DC. p. 279
Broka, J. B. and Randie, M. (1996) Application of String Comparsion Techniques in QSAR Studies. J. Com. Chem. 7, 176-188
Heritage, T. W. and Lowis, D. R. (1999) Molecular hologram QSAR. In Rational drug design: Novel Methodology and Practical Applications (ed. Parrill, A. L. and M. R. Reddy), ACS Symposium Series 719, ACS. Washington, DC. Ch. 4
Tong, W., Lowis, D. R., Perkins, R., Chen, Y., Welsh, W. J., Goddette, D. W., Heritage, T. W. and Sheehan, D. M. (1998) Exaluation of quantitative structure activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor. J. Chem. Inf. Comput. Sci. 38, 669-677
Mager, P. P. (1998) In Multivatiate Chemometrics in QSAR: A Dialogue. Letchworth, Hertfordshire, England, Wiley
Dunn, W. J. III. (1977) Molar refractivity as an independent variable in quantitative structure-activity studies. Eur. J. Med. Chem. 12, 109-127
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.